Marie Wikström Lindholm
Technik-/Wissenschafts-/F&E-Leiter bei SILENCE THERAPEUTICS PLC
Ursprung des Netzwerks ersten Grades von Marie Wikström Lindholm
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Miscellaneous Commercial Services | 28 | |
University of Lund
27
| College/University | Other Consumer Services | 27 |
Oligonucleotide Therapeutics Society, Inc.
 Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators.
13
| Subsidiary | Miscellaneous Commercial Services | 13 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Marie Wikström Lindholm
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| E-THERAPEUTICS PLC | Biotechnology | Chairman Chief Executive Officer Chief Operating Officer Corporate Officer/Principal | |
| University of Cambridge | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
| The University of Chicago | College/University | Masters Business Admin Corporate Officer/Principal | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| PEPGEN INC. | Biotechnology | Founder Corporate Officer/Principal | |
| The University of Edinburgh | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Copenhagen | College/University | Graduate Degree Corporate Officer/Principal | |
| REX INTERNATIONAL HOLDING LIMITED | Integrated Oil | Founder Chief Executive Officer | |
Proteros biostructures GmbH
 Proteros biostructures GmbH Medical/Nursing ServicesHealth Services Proteros biostructures GmbH is a holding company which serves as a discovery service business. Its business areas are Discovery Pipeline, Discovery Services and Science & Technology. The Discovery Pipeline focuses on protein biochemistry, X-ray crystallography, biophysics, computational chemistry and property driven medicinal chemistry, Discovery Services offers drug discovery services with expertise and proprietary technologies for protein production, protein structure analysis, kinetic and thermodynamic profiling and Science & Technology segment focuses on industrialized structure-guided lead development infrastructure. The company was founded by Robert Huber and Torsten Neuefeind in 1999 and is headquartered in Martinsried, Germany. | Medical/Nursing Services | Director of Finance/CFO Chief Executive Officer | |
| University College London | College/University | Doctorate Degree Graduate Degree | |
Rex US Ltd.
 Rex US Ltd. Financial ConglomeratesFinance Part of Rex International Holding Ltd., Rex US Ltd. operates as an investment company. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| HÖVDING SVERIGE AB (PUBL) | Recreational Products | Founder Chief Executive Officer | |
PA Consulting Group Ltd.
 PA Consulting Group Ltd. Miscellaneous Commercial ServicesCommercial Services PA Consulting Group Ltd. engages in the provision of management, systems, technology consulting, and innovation services. The company was founded by Ernest Button on September 3, 2015 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
| Rex South East Asia Ltd. | Director/Board Member Director/Board Member | ||
| PHARNEXT SCA | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
| IDOGEN AB (PUBL) | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| PREMIER VETERINARY GROUP PLC | Agricultural Commodities/Milling | Chairman Comptroller/Controller/Auditor | |
| ARATANA THERAPEUTICS INC | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| Lund University Hospital | Corporate Officer/Principal Corporate Officer/Principal | ||
| Nanoecho AB | Director/Board Member Director/Board Member | ||
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Respiratorius AB
 Respiratorius AB Pharmaceuticals: MajorHealth Technology Respiratorius AB engages in the development of drug candidates for Chronic Obstructive Pulmonary Disease, asthma, and cancer. The company was founded by Lars Christer Fedrik Fåhraeus and Staffan Skogwall in 1999 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member Founder | |
| READSOFT AB | Packaged Software | Chief Operating Officer | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Corporate Officer/Principal | |
| VIRACTA THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
Orchard Therapeutics North America
 Orchard Therapeutics North America BiotechnologyHealth Technology Part of Orchard Therapeutics Plc, Orchard Therapeutics North America provides biotechnology research services. The company is based in Boston, MA. The CEO of the company is Bobby Gaspar. | Biotechnology | President | |
| IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genpharm Services
 Genpharm Services Advertising/Marketing ServicesCommercial Services Genpharm Services operates as a pharmaceutical company providing partners with market access and commercial solutions into the Middle East and North Africa region. It also acts as a commercial partner for rare genetic diseases, orphan drugs, and specialty therapeutics and offers strategic advice on disease areas, product launches and go-to markets strategies. The company was founded by Karim Smaira and Kamel Ghammachi in 2012 and is headquartered in Dubai, United Arab Emirates. | Advertising/Marketing Services | Director/Board Member | |
| ORCHARD THERAPEUTICS PLC | Pharmaceuticals: Major | Chief Executive Officer | |
Orchard Therapeutics (Europe) Ltd.
 Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Chief Executive Officer | |
| PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| INSEAD | College/University | Masters Business Admin | |
| AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SKYE BIOSCIENCE, INC. | Pharmaceuticals: Major | Director/Board Member | |
| British Heart Foundation | Miscellaneous Commercial Services | Director/Board Member | |
| MEREO BIOPHARMA GROUP PLC | Biotechnology | Director/Board Member | |
| Secret Saviours Ltd. | Director/Board Member | ||
Noxsudor Therapeutics Ltd.
 Noxsudor Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Noxsudor Therapeutics Ltd. manufactures capsules that control sweating. | Pharmaceuticals: Major | Director/Board Member | |
Ryse Asset Management LLP
 Ryse Asset Management LLP Investment ManagersFinance RYSE Asset Management LLP (RYSE) is a venture capital firm founded in 2010 by Atique Mirza. The firm is headquartered in London, the United Kingdom. | Investment Managers | Chairman | |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Medical Specialties | President | |
Sigarth AB
 Sigarth AB Electronic Equipment/InstrumentsElectronic Technology Sigarth AB engages in the manufacture of radiator suspension systems and accessories. Its products include ventplus air ventilation, brackets mounted on grills and welding seam, brackets mounted on lugs, safety products, floor brackets, waterproof cabinets, and grills and side covers. The company is headquartered in Hillerstorp, Sweden. | Electronic Equipment/Instruments | Director/Board Member | |
Girindus America, Inc.
 Girindus America, Inc. Pharmaceuticals: MajorHealth Technology Part of Nitto Denko Corp., Girindus America, Inc. provides oligonucleotide research and production services. The company is based in Cincinnati, OH. The CEO of the company is Marc M. Lemaître. Girindus America was acquired by Nitto Denko Avecia, Inc. from Girindus AG i.L. on January 30, 2013 for $12.60 million. | Pharmaceuticals: Major | Chief Executive Officer |
Statistik
International
| Vereinigte Staaten | 18 |
| Vereinigtes Königreich | 15 |
| Schweden | 9 |
| Dänemark | 3 |
| Singapur | 3 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 7 |
| Commercial Services | 4 |
| Health Services | 3 |
| Finance | 3 |
Operativ
| Director/Board Member | 284 |
| Corporate Officer/Principal | 113 |
| Chairman | 68 |
| Chief Executive Officer | 63 |
| Founder | 45 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Annalisa Jenkins | 51 |
| Andrew Richards | 44 |
| Iain Ross | 41 |
| Stephen Parker | 34 |
| James Ede-Golightly | 29 |
| Michael Davidson | 27 |
| David Lemus | 22 |
| Craig Tooman | 22 |
| David Solomon | 22 |
| Eric Floyd | 18 |
| Sofia Svensson | 17 |
| Mark Rothera | 14 |
| Karl Helge Tore Lidgren | 13 |
| Felix Erhardt | 13 |
| Inga Sarah Maria Fredriksson | 13 |
- Börse
- Insiders
- Marie Wikström Lindholm
- Unternehmensverbindungen
